Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

Core Viewpoint - Tango Therapeutics, Inc. is actively participating in the 2025 Cantor Global Healthcare Conference, highlighting its commitment to engaging with investors and the healthcare community [1]. Company Overview - Tango Therapeutics is a clinical-stage biotechnology company focused on discovering novel drug targets and advancing precision medicine for cancer treatment [3]. - The company employs the genetic principle of synthetic lethality to develop therapies targeting critical cancer-related pathways [3]. - More information about the company can be found on its official website [3]. Event Details - Barbara Weber, M.D., the President and CEO of Tango Therapeutics, will participate in a fireside chat at the conference on September 3, 2025, from 2:45 to 3:15 PM ET [1]. - A live webcast of the event will be available on the company's website, with a replay accessible for 90 days post-presentation [2].